Cumberland PharmaceuticalsCPIX
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 27 institutions reported holding Cumberland Pharmaceuticals (CPIX) in their 13F filings, down 3 from Q3 2025. 4 opened new positions and 7 sold out. The largest holders were Ikarian Capital, LLC ($2.2M), Renaissance Technologies ($1.9M) and Vanguard Group Inc. ($1.6M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Cumberland Pharmaceuticals
- CUSIP
- 230770109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $1.7M |
| Exits | 7 | $1.9M |
All 13F filers, Q3 2025 → Q4 2025: 436,569 shares bought and 885,132 shares sold, net −448,563 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 27 holders
| Ikarian Capital, LLC | 0.29% | No change | 555,932 | $2.2M |
| Renaissance Technologies | 0.00% | Reduce -8.4% | 472,163 | $1.9M |
| Vanguard Group Inc. | 0.00% | No change | 411,786 | $1.6M |
| Perceptive Advisors LLC | 0.02% | New | 341,087 | $1.4M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -3.1% | 272,278 | $1.1M |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -13.2% | 163,468 | $651K |
| Boothbay Fund Management, LLC | 0.01% | Reduce -23.6% | 128,507 | $511K |
| Geode Capital Management, LLC | 0.00% | Add +5.6% | 107,274 | $427K |
| J. Goldman & Co LP | 0.01% | Reduce -54.6% | 94,541 | $376K |
| Bank of New York Mellon Corp | 0.00% | No change | 72,513 | $289K |
| BlackRock, Inc. | 0.00% | Add +0.9% | 52,577 | $209K |
| Marshall Wace, LLP | 0.00% | New | 48,137 | $192K |
| Acadian Asset Management LLC | 0.00% | No change | 44,288 | $176K |
| State Street Corp. | 0.00% | No change | 33,700 | $134K |
| Heron Bay Capital Management | 0.02% | Reduce -7.8% | 29,189 | $116K |
| Susquehanna International Group, LLP | 0.00% | New | 26,038 | $104K |
| Two Sigma Investments, LP | 0.00% | Reduce -34.9% | 24,485 | $97K |
| Citadel Advisors | 0.00% | Reduce -47.0% | 21,957 | $87K |
| Northern Trust Corp. | 0.00% | No change | 19,603 | $78K |
| Cresset Asset Management, LLC | 0.00% | Reduce -5.4% | 17,475 | $70K |
| UBS Group AG | 0.00% | Add +1760.5% | 15,386 | $61K |
| Morgan Stanley | 0.00% | Reduce -9.6% | 3,260 | $13K |
| NewEdge Advisors, LLC | 0.00% | Add +59.1% | 1,203 | $5K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 437 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 200 | $796 |
| Bank of America Corp. | 0.00% | Reduce -47.1% | 9 | $36 |
| Huntington National Bank | 0.00% | No change | 1 | $4 |
"% of holder's portfolio" is CPIX's weight in each manager's 13F, not the share of Cumberland Pharmaceuticals the manager owns.